IP Library Granted Patent US 10,485,877
Granted Patent B2
US 10,485,877 · App. 15/968,561 · Granted Nov 26, 2019

Oligomer-phenothiazine conjugates

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,485,877
App. No.
15/968,561
Granted
Nov 26, 2019
Kind
B2
Abstract

The invention relates to (among other things) oligomer-phenothiazine conjugates and related compounds. A conjugate of the invention, when administered by any of a number of administration routes, exhibits advantages over un-conjugated phenothiazine compounds.

Claims (23)

1. A compound having the formula:

R 1 , R 2 , R 3 , and R 4 , each independently are selected from the group consisting of hydrogen, unsubstituted alkyl, and substituted alkyl; or R 3 and R 4 together with the nitrogen form a heterocycle;

n is an integer equal to or greater than one;

X is a spacer moiety; and

POLY is a water-soluble, non-peptidic oligomer.

2. The compound of claim 1 , wherein the water-soluble, non-peptidic oligomer is a poly(alkylene oxide).

3. The compound of claim 2 , wherein the poly(alkylene oxide) is a poly(ethylene oxide).

4. The compound of claim 1 , wherein water-soluble, non-peptidic oligomer is made of from about 1 to about 30 monomers.

5. The compound of claim 4 , wherein the water-soluble, non-peptidic oligomer is made of from about 1 to about 10 monomers.

6. The compound of claim 2 , wherein the poly(alkylene oxide) includes an alkoxy or hydroxy end-capping moiety.

7. The compound of claim 1 , wherein a single water-soluble, non-peptidic oligomer is attached to the phenothiazine residue.

8. The compound of claim 1 , wherein more than one water-soluble, non-peptidic oligomer is attached to the phenothiazine residue.

9. The compound of claim 1 , wherein the phenothiazine residue is covalently attached via a stable linkage.

10. The compound of claim 1 , wherein the phenothiazine residue is covalently attached via a degradable linkage.

11. The compound of claim 1 , wherein the linkage is an ether linkage.

12. The compound of claim 1 , wherein the linkage is an ester linkage.

13. A composition comprising the compound of claim 1 , and a pharmaceutically acceptable excipient.

14. The compound of claim 1 , wherein POLY is —(CH 2 CH 2 O) n Y,

wherein Y is selected from H and —CH 3 ; and

n is 1 to 30.

15. The compound of claim 1 , wherein X is —O— or a bond.

16. The compound of claim 1 , having the formula:

17. The compound of claim 1 , having the formula:

Assignments (2)
RELEASE OF SECURITY INTEREST Recorded Apr 17, 2020
From: TC LENDING, LLC, AS COLLATERAL AGENT
To: NEKTAR THERAPEUTICS
Reel/Frame 053180/0009 →
SECURITY INTEREST Recorded Jul 23, 2018
From: NEKTAR THERAPEUTICS
To: TC LENDING, LLC, AS COLLATERAL AGENT
Reel/Frame 046607/0825 →